Implantable devices that combine cardiac resynchronization therapy and defibrillation to reduce chronic heart failure events in patients with asymptomatic or mild to moderate heart failure (NYHA Class I/II).
If you have a Hayes login, click here to view the full report on the Knowledge Center.